中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2014年
20期
3593-3597
,共5页
王翼洁%胡文彬%余小玲%吴君霞%韩咏竹%胡纪源%王训%李凯%王共强%杨任民
王翼潔%鬍文彬%餘小玲%吳君霞%韓詠竹%鬍紀源%王訓%李凱%王共彊%楊任民
왕익길%호문빈%여소령%오군하%한영죽%호기원%왕훈%리개%왕공강%양임민
肝豆状核变性%同型半胱氨酸%驱铜治疗
肝豆狀覈變性%同型半胱氨痠%驅銅治療
간두상핵변성%동형반광안산%구동치료
Hepatolenticular degeneration%Homocysteine%Decoppering therapy
目的:探讨肝豆状核变性(HLD)患者同型半胱氨酸与血浆脂蛋白(a)、维生素B12、叶酸相关性及与驱铜治疗的关系。方法将63例HLD住院患者分为33例HLD规范治疗组(规范组)和30例HLD非规范治疗组(非规范组),测定二巯基丙磺酸钠(DMPS)驱铜疗程前血浆同型半胱氨酸(Hcy)、脂蛋白(a)、维生素B12及叶酸的水平,并留取患者疗前和第一个DMPS驱铜疗程中的24 h尿铜,以35例正常人为健康对照组。结果非规范组患者血浆Hcy异常率显著高于规范组及对照组(P<0.0167),而规范组与对照组Hcy异常率无统计学差异(P>0.05)。三组患者脂蛋白(a)、叶酸均有统计学差异(P<0.05),而维生素 B12水平无统计学差异(P>0.05)。非规范组疗前、第一疗程尿铜显著高于规范组(P<0.05),且非规范组患者血浆Hcy与第一疗程尿铜呈线性正相关。对照组血浆维生素B12、叶酸对Hcy具有显著负相关,而脂蛋白(a)对Hcy具有不显著正相关。结论未经规范化驱铜治疗的HLD患者更易合并高Hcy血症;HLD患者存在脂蛋白(a)的代谢异常及叶酸缺乏情况;正常人的血浆脂蛋白(a)、叶酸、维生素B12水平与血浆Hcy水平存在相关性,但有关HLD的相关性有待进一步研究。
目的:探討肝豆狀覈變性(HLD)患者同型半胱氨痠與血漿脂蛋白(a)、維生素B12、葉痠相關性及與驅銅治療的關繫。方法將63例HLD住院患者分為33例HLD規範治療組(規範組)和30例HLD非規範治療組(非規範組),測定二巰基丙磺痠鈉(DMPS)驅銅療程前血漿同型半胱氨痠(Hcy)、脂蛋白(a)、維生素B12及葉痠的水平,併留取患者療前和第一箇DMPS驅銅療程中的24 h尿銅,以35例正常人為健康對照組。結果非規範組患者血漿Hcy異常率顯著高于規範組及對照組(P<0.0167),而規範組與對照組Hcy異常率無統計學差異(P>0.05)。三組患者脂蛋白(a)、葉痠均有統計學差異(P<0.05),而維生素 B12水平無統計學差異(P>0.05)。非規範組療前、第一療程尿銅顯著高于規範組(P<0.05),且非規範組患者血漿Hcy與第一療程尿銅呈線性正相關。對照組血漿維生素B12、葉痠對Hcy具有顯著負相關,而脂蛋白(a)對Hcy具有不顯著正相關。結論未經規範化驅銅治療的HLD患者更易閤併高Hcy血癥;HLD患者存在脂蛋白(a)的代謝異常及葉痠缺乏情況;正常人的血漿脂蛋白(a)、葉痠、維生素B12水平與血漿Hcy水平存在相關性,但有關HLD的相關性有待進一步研究。
목적:탐토간두상핵변성(HLD)환자동형반광안산여혈장지단백(a)、유생소B12、협산상관성급여구동치료적관계。방법장63례HLD주원환자분위33례HLD규범치료조(규범조)화30례HLD비규범치료조(비규범조),측정이구기병광산납(DMPS)구동료정전혈장동형반광안산(Hcy)、지단백(a)、유생소B12급협산적수평,병류취환자료전화제일개DMPS구동료정중적24 h뇨동,이35례정상인위건강대조조。결과비규범조환자혈장Hcy이상솔현저고우규범조급대조조(P<0.0167),이규범조여대조조Hcy이상솔무통계학차이(P>0.05)。삼조환자지단백(a)、협산균유통계학차이(P<0.05),이유생소 B12수평무통계학차이(P>0.05)。비규범조료전、제일료정뇨동현저고우규범조(P<0.05),차비규범조환자혈장Hcy여제일료정뇨동정선성정상관。대조조혈장유생소B12、협산대Hcy구유현저부상관,이지단백(a)대Hcy구유불현저정상관。결론미경규범화구동치료적HLD환자경역합병고Hcy혈증;HLD환자존재지단백(a)적대사이상급협산결핍정황;정상인적혈장지단백(a)、협산、유생소B12수평여혈장Hcy수평존재상관성,단유관HLD적상관성유대진일보연구。
Objective To explore the correlation between plasma homocysteine and lipoprotein (a), folate, Vitamin B12 in hepatolenticular degeneration(HLD) and the relationship with decoppering therapy. Methods 63 inpatients of HLD were divided into 33 cases of standardized treatment group(specification group) and 30 cases of non-standardized treatment group(non-specification group). The serum concentration of homocysteine(Hcy), lipoprotein (a), folate and vitamin B12 were measured before decoppering therapy with sodium dimercaptosulphonate(DMPS), 24-hour urine copper were remained before drug treatment and after first period treatment with DMPS. 35 cases of normal served as controls(control group). Results The abnormal rate of serum Hcy in non-specification group was higher than that in specification group and control group(P<0.05), but there was no statistical significance between specification group and control group(P>0.05). The concentration of lipoprotein (a) and folate between three groups had statistical significance(P<0.05), but vitamin B12 among the three groups present no statistical significance(P>0.05). 24-hour urine before drug treatment and after first period treatment with DMPS in non-specification group were higher than that in specification group(P<0.05), and 24-hour urine after first period treatment with DMPS had positively linearly related to serum Hcy in non-specification group. The serum concentration of vitamin B12 and folate had a significant negatively related to Hcy in control group, but lipoprotein(a) had no significant positively related to Hcy. Conclusions HLD patients without standardized decoppering therapy are more easily complicated with hyperhomocysteine. HLD patients have metabolic abnormalities of lipoprotein(a) and folate deficiency. The correlation between hyperhomocycteinemia and lipoprotein(a), folate, vitamin B12 is existed in normal human, but this correlation in HLD patients remains to be further exploration.